Indication
Active lupus nephritis
Active lupus nephritis is an acute or relapsing autoimmune inflammatory glomerulonephritis occurring in patients with systemic lupus erythematosus, representing a major driver of chronic renal morbidity and mortality. Read more about Active lupus nephritis
5 drugs 3 manufacturers
Drugs that treat it
Common Active lupus nephritis therapies.
GAZYVA (obinutuzumab)
BENLYSTA (belimumab)
BENLYSTA (belimumab)
LUPKYNIS (voclosporin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonActive lupus nephritis is an acute or relapsing autoimmune inflammatory glomerulonephritis occurring in patients with systemic lupus erythematosus, representing a major driver of chronic renal morbidity and mortality.
It develops when circulating or in situ autoantibodies and immune complexes deposit within the renal mesangium, subendothelium, or subepithelial compartments, inciting complement cascade activation and local cellular infiltration.
Clinically and histopathologically, active disease is defined by ongoing renal inflammation manifesting as marked proteinuria, active urinary sediment with microscopic hematuria or cellular casts, declining glomerular filtration, and biopsy findings such as endocapillary proliferation, cellular crescents, or fibrinoid necrosis.
- nih.gov
Active lupus nephritis is an acute or relapsing autoimmune inflammatory glomerulonephritis occurring in patients with systemic lupus erythematosus, representing a major driver of chronic renal morbidity and mortality Clinically and histopathologically, active disease is defined by ongoing renal inflammation manifesting as marked proteinuria, active urinary sediment with microscopic hematuria or cellular casts, declining glomerular filtration, and biopsy findings such as endocapillary proliferati...
- nih.gov
Active lupus nephritis is an acute or relapsing autoimmune inflammatory glomerulonephritis occurring in patients with systemic lupus erythematosus, representing a major driver of chronic renal morbidity and mortality
- nih.gov
Active lupus nephritis is an acute or relapsing autoimmune inflammatory glomerulonephritis occurring in patients with systemic lupus erythematosus, representing a major driver of chronic renal morbidity and mortality It develops when circulating or in situ autoantibodies and immune complexes deposit within the renal mesangium, subendothelium, or subepithelial compartments, inciting complement cascade activation and local cellular infiltration
- nih.gov
It develops when circulating or in situ autoantibodies and immune complexes deposit within the renal mesangium, subendothelium, or subepithelial compartments, inciting complement cascade activation and local cellular infiltration
- merckmanuals.com
It develops when circulating or in situ autoantibodies and immune complexes deposit within the renal mesangium, subendothelium, or subepithelial compartments, inciting complement cascade activation and local cellular infiltration Clinically and histopathologically, active disease is defined by ongoing renal inflammation manifesting as marked proteinuria, active urinary sediment with microscopic hematuria or cellular casts, declining glomerular filtration, and biopsy findings such as endocapillar...
- nih.gov
Clinically and histopathologically, active disease is defined by ongoing renal inflammation manifesting as marked proteinuria, active urinary sediment with microscopic hematuria or cellular casts, declining glomerular filtration, and biopsy findings such as endocapillary proliferation, cellular crescents, or fibrinoid necrosis
- consultant360.com
Clinically and histopathologically, active disease is defined by ongoing renal inflammation manifesting as marked proteinuria, active urinary sediment with microscopic hematuria or cellular casts, declining glomerular filtration, and biopsy findings such as endocapillary proliferation, cellular crescents, or fibrinoid necrosis
Personalize your experience
Follow Active lupus nephritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.